SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity

Kevin H. Toomer(Johns Hopkins University), Ivo M.B. Francischetti(Johns Hopkins University), Jody E. Hooper(Johns Hopkins University), Laetitia Daou(Johns Hopkins University), Yifan Zhang(Anhui Agricultural University), Michael Tushek(Johns Hopkins University), Gloria F. Gerber(Johns Hopkins University)
eJHaem
February 23, 2023
Cited by 15


Related Papers